Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Infinity Pharmaceuticals, Inc.

INFI•NASDAQ
Healthcare
Biotechnology
$0.008
$-0.01(-52.38%)
U.S. Market opens in 1h 31m

Infinity Pharmaceuticals, Inc. (INFI) Stock Overview

Explore Infinity Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap726.1K
P/E Ratio-0.02
EPS (TTM)$-0.44
ROE-34.33%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

INFI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Infinity Pharmaceuticals, Inc. (INFI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.02 and a market capitalization of 726.1K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
77.78%
5-Day Change
72.79%
1-Month Change
-50.00%
3-Month Change
-93.85%
6-Month Change
-95.56%
Year-to-Date (YTD) Change
-98.60%
1-Year Change
-99.35%
3-Year Change
-99.27%
5-Year Change
-99.61%
All-Time (Max) Change
-99.99%

Contact Information

https://www.infi.com
617 453 1000
1100 Massachusetts Avenue, Cambridge, MA, 02138

Company Facts

300 Employees
IPO DateJul 28, 2000
CountryUS

Frequently Asked Questions